Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Everest transforms into a commercial-stage innovative biopharmaceutical company SHANGHAI, July 26, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.